JPRN-jRCT2031220749进行中（未招募）Unknown
Post-marketing database survey [Spykevax intramuscular injection (monovalent: strain of origin) ] Acute safety cohort study of subjects with underlying diseases considered to be at high risk of severe COVID-19 infection utilizing vaccination information
chida Akira0 个研究点目标入组 3,000 人开始时间: 2023年3月31日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Target number of patients: 3,000; persons who have responded to the Acute-Specific Adverse Events Questionnaire among those who have been registered for vaccination with PeP Up and have the underlying diseases listed below.
- •(Definition of persons with underlying diseases)
- •Based on the definitions of underlying diseases that are positioned at the top of the order of immunization based on the current medical knowledge, etc., reviewed at the 43rd Meeting of the Subcommittee on Immunization and Vaccine of the Health Sciences Council (held on December 25, 2020), the following diseases that are considered extractable from the JMDC database are defined as diseases for this survey. The following diseases are considered to be extractable from the JMDC database. 1.
- •1. chronic respiratory disease
- •2. chronic heart disease (including hypertension)
- •Chronic kidney disease
- •4. chronic liver disease (e.g., cirrhosis)
- •5. diabetes mellitus being treated with insulin or oral medication or diabetes mellitus with other concomitant illnesses
- •6. blood diseases (except iron deficiency anemia) 7. diseases of the blood (but excluding iron deficiency anemia) and diseases that impair the function of the immune system (including malignant tumors under treatment)
- •7. treatment for immune system deterioration, such as steroids
- •8. chromosomal abnormalities
- •9. severe mental or physical disability (a combination of severe physical disability and severe intellectual disability)
- •10. sleep apnea syndrome
- •11. obesity (BMI over 30)
排除标准
- •Not applicable
研究者
相似试验
进行中（未招募）
Unknown
Post-marketing database survey [Spykevax intramuscular injection (monovalent: strain of original) ] Non-acute safety cohort study of persons with underlying diseases considered to be at high risk of severe COVID-19 infection utilizing vaccination informatioJPRN-jRCT2031220748chida Akira8,000
进行中（未招募）
Unknown
Post-marketing database survey [Spykevax intramuscular injection (monovalent: strain of original) ] Cohort study on shock and anaphylaxis in subjects with underlying diseases considered to be at high risk of severe COVID-19 infection by utilizing vaccination informatioJPRN-jRCT2031220747chida Akira8,000
尚未招募
Unknown
A Database Survey of Comparison The Risk of Haemorrhage between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants with DepressioDepressionJPRN-jRCT2031230194Contact for Clinical Trial Information115,000
尚未招募
4 期
A Post Marketing Surveillance of inj. mycobacterium w in patients with Gram Negative SepsisCTRI/2023/03/051018Cadila Pharmaceuticals Ltd.
已完成
不适用
A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding.ConstipationJPRN-UMIN000048410estle Health Science Company, Nestle Japan Ltd.184